The EU-supported EuroFlow Consortium aimed at innovation and standardization of immunophenotyping for diagnosis and classification of hematological malignancies by introducing 8-color flow cytometry with fully standardized laboratory procedures and antibody panels in order to achieve maximally comparable results among different laboratories. This required the selection of optimal combinations of compatible fluorochromes and the design and evaluation of adequate standard operating procedures (SOPs) for instrument setup, fluorescence compensation and sample preparation. Additionally, we developed software tools for the evaluation of individual antibody reagents and antibody panels. Each section describes what has been evaluated experimentally versus adopted based on existing data and experience. Multicentric evaluation demonstrated high levels of reproducibility based on strict implementation of the EuroFlow SOPs and antibody panels. Overall, the 6 years of extensive collaborative experiments and the analysis of hundreds of cell samples of patients and healthy controls in the EuroFlow centers have provided for the first time laboratory protocols and software tools for fully standardized 8-color flow cytometric immunophenotyping of normal and malignant leukocytes in bone marrow and blood; this has yielded highly comparable data sets, which can be integrated in a single database.

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues4th edn.International Agency for Research on Cancer: Lyon; 2008. 439 pp.

Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D, et al. Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom. 2007;72 (Suppl 1:S5–S13. PubMed

Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, et al. Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom. 2007;72 (Suppl 1:S14–S22. PubMed

Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry. 1997;30:231–235. PubMed

Stetler-Stevenson M, Ahmad E, Barnett D, Braylan R, DiGiuseppe J, Marti G, et al. Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells. Approved guideline. 2nd edn. CLSI document H43-A2 ed. Clinical and Laboratory Standards Institute: Wayne, PA, 2007.

Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol. 2004;4:648–655. PubMed

Baumgarth N, Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods. 2000;243:77–97. PubMed

Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111:3941–3967. PubMed

van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Drager AM, Feuillard J, et al. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica. 2009;94:1124–1134. PubMed PMC

Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93:431–438. PubMed

Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry B Clin Cytom. 2006;70:39–44. PubMed

Owens MA, Vall HG, Hurley AA, Wormsley SB. Validation and quality control of immunophenotyping in clinical flow cytometry. J Immunol Methods. 2000;243:33–50. PubMed

Davis BH, Foucar K, Szczarkowski W, Ball E, Witzig T, Foon KA, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry. 1997;30:249–263. PubMed

Bene MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 2011;25:567–574. PubMed

Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay. Clin Lab Med. 2007;27:469–485. PubMed PMC

Roederer M, Kantor AB, Parks DR, Herzenbergzzz LA. Cy7PE and Cy7APC: bright new probes for immunofluorescence. Cytometry. 1996;24:191–197. PubMed

Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, Markelov ML, et al. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat Biotechnol. 1999;17:969–973. PubMed

Berlier JE, Rothe A, Buller G, Bradford J, Gray DR, Filanoski BJ, et al. Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates. J Histochem Cytochem. 2003;51:1699–1712. PubMed

Telford W, Kapoor V, Jackson J, Burgess W, Buller G, Hawley T, et al. Violet laser diodes in flow cytometry: an update. Cytometry A. 2006;69:1153–1160. PubMed

Abrams B, Diwu Z, Guryev O, Aleshkov S, Hingorani R, Edinger M, et al. 3-Carboxy-6-chloro-7-hydroxycoumarin: a highly fluorescent, water-soluble violet-excitable dye for cell analysis. Anal Biochem. 2009;386:262–269. PubMed

Maecker H, Trotter J.Selecting Reagents for Multicolor Flow Cytometry. Application Note. BD Biosciences: San Jose, CA, 2009. PubMed

Stewart CC, Stewart SJ. Four color compensation. Cytometry. 1999;38:161–175. PubMed

Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry. 2001;45:194–205. PubMed

Maecker HT, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry A. 2004;62:169–173. PubMed

Wood B. 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med. 2006;130:680–690. PubMed

Kraan J, Gratama JW, Haioun C, Orfao A, Plonquet A, Porwit A, et al. Flow cytometric immunophenotyping of cerebrospinal fluid Curr Protoc Cytom 2008. Chapter 6: Unit 6 25. PubMed PMC

Basso G, Buldini B, De Zen L, Orfao A. New methodologic approaches for immunophenotyping acute leukemias. Haematologica. 2001;86:675–692. PubMed

McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, et al. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach. Cytometry A. 2008;73:400–410. PubMed PMC

van Dongen JJM, Lhermitte L, Böttcher S, Almeida J, van der Velden VHJ, Flores-Montero J, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes Leukemia 2012. doi:10.1038/leu.2012.120 PubMed DOI PMC

Le Roy C, Varin-Blank N, Ajchenbaum-Cymbalista F, Letestu R. Flow cytometry APC-tandem dyes are degraded through a cell-dependent mechanism. Cytometry A. 2009;75:882–890. PubMed

Hulett HR, Bonner WA, Sweet RG, Herzenberg LA. Development and application of a rapid cell sorter. Clin Chem. 1973;19:813–816. PubMed

Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A. 2006;69:1037–1042. PubMed

Perfetto SP, Ambrozak D, Nguyen R, Chattopadhyay P, Roederer M. Quality assurance for polychromatic flow cytometry. Nat Protoc. 2006;1:1522–1530. PubMed

Hughes OR, Stewart R, Dimmick I, Jones EA. A critical appraisal of factors affecting the accuracy of results obtained when using flow cytometry in stem cell investigations: where do you put your gates. Cytometry A. 2009;75:803–810. PubMed

Shapiro HM.Excitation and emission spectra of common dyes Curr Protoc Cytom 2004. Chapter 1: Unit 1 19. PubMed

Tung JW, Parks DR, Moore WA, Herzenberg LA. New approaches to fluorescence compensation and visualization of FACS data. Clin Immunol. 2004;110:277–283. PubMed

Roederer M.Compensation in flow cytometry Curr Protoc Cytom 200211Chapter 1: Unit 1 14. PubMed

Groeneveld K, te Marvelde JG, van den Beemd MW, Hooijkaas H, van Dongen JJ. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia. 1996;10:1383–1389. PubMed

Macey MG, McCarthy DA, Milne T, Cavenagh JD, Newland AC. Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry. Cytometry. 1999;38:153–160. PubMed

Stewart CC, Stewart SJ.Immunophenotyping Curr Protoc Cytom 2001. Chapter 6: Unit 6 2. PubMed

Holmes K, Lantz LM, Fowlkes BJ, Schmid I, Giorgi JV.Preparation of cells and reagents for flow cytometry Curr Protoc Immunol 2001. Chapter 5: Unit 5 3. PubMed

Kappelmayer J, Gratama JW, Karaszi E, Menendez P, Ciudad J, Rivas R, et al. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols. J Immunol Methods. 2000;242:53–65. PubMed

Quijano S, Lopez A, Sancho JM, Panizo C, Deben G, Castilla C, et al. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. J Clin Oncol. 2009;27:1462–1469. PubMed

Owens MA, Loken MR.Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping Wiley-Liss: New York; Chichester; 1995. xiii, 224 pp.

Caraux A, Klein B, Paiva B, Bret C, Schmitz A, Fuhler GM, et al. Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells. Haematologica. 2010;95:1016–1020. PubMed PMC

Braylan RC, Orfao A, Borowitz MJ, Davis BH. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry. 2001;46:23–27. PubMed

Sanchez ML, Almeida J, Vidriales B, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16:1460–1469. PubMed

Pedreira CE, Costa ES, Barrena S, Lecrevisse Q, Almeida J, van Dongen JJ, et al. Generation of flow cytometry data files with a potentially infinite number of dimensions. Cytometry A. 2008;73:834–846. PubMed

Pedreira CE, Costa ES, Almeida J, Fernandez C, Quijano S, Flores J, et al. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders. Cytometry A. 2008;73A:1141–1150. PubMed

Costa ES, Pedreira CE, Barrena S, Lecrevisse Q, Flores J, Quijano S, et al. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping. Leukemia. 2010;24:1927–1933. PubMed PMC

Costa ES, Arroyo ME, Pedreira CE, Garcia-Marcos MA, Tabernero MD, Almeida J, et al. A new automated flow cytometry data analysis approach for the diagnostic screening of neoplastic B-cell disorders in peripheral blood samples with absolute lymphocytosis. Leukemia. 2006;20:1221–1230. PubMed

Robinson JP, Durack G, Kelley S. An innovation in flow cytometry data collection and analysis producing a correlated multiple sample analysis in a single file. Cytometry. 1991;12:82–90. PubMed

Robinson JP, Ragheb K, Lawler G, Kelley S, Durack G. Rapid multivariate analysis and display of cross-reacting antibodies on human leukocytes. Cytometry. 1992;13:75–82. PubMed

Cover TM, Hart PE. Nearest neighbour pattern clasification. IEEE Trans Inf Theory. 1967;IT-13:21–27.

Duda RO, Hart PE, Stork DG, RO Duda.PC, scene aIn: Duda RO, Hart PE, Stork DG, (eds)Pattern Classification2nd ednWiley: New York; Chichester; 2001. 654 pp.

Costa ES, Peres RT, Almeida J, Lecrevisse Q, Arroyo ME, Teodosio C, et al. Harmonization of light scatter and fluorescence flow cytometry profiles obtained after staining peripheral blood leucocytes for cell surface-only versus intracellular antigens with the Fix & Perm reagent. Cytometry B Clin Cytom. 2010;78:11–20. PubMed

Lugli E, Roederer M, Cossarizza A. Data analysis in flow cytometry: the future just started. Cytometry A. 2010;77:705–713. PubMed PMC

Stall A.Qr and Br in BD FACSDiva v6 Software: Parameters for Characterizing Detector Performance. Application Note 23-10516-00. BD Biosciences: San Diego, CA, 2008.

Bjorklund E, Matinlauri I, Tierens A, Axelsson S, Forestier E, Jacobsson S, et al. Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment. J Pediatr Hematol Oncol. 2009;31:406–415. PubMed

Dworzak MN, Gaipa G, Ratei R, Veltroni M, Schumich A, Maglia O, et al. Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: multicentric assessment is feasible. Cytometry B Clin Cytom. 2008;74:331–340. PubMed

Irving J, Jesson J, Virgo P, Case M, Minto L, Eyre L, et al. Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting. Haematologica. 2009;94:870–874. PubMed PMC

Kraan J, Gratama JW, Keeney M, D'Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agents. 2003;17:223–233. PubMed

Shankey TV, Forman M, Scibelli P, Cobb J, Smith CM, Mills R, et al. An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2006;70:259–269. PubMed

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia

Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of juvenile myelomonocytic leukemia

Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination

Diagnosing Czech Patients with Inherited Platelet Disorders

Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome

Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial

Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network

EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children

Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools

Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model

CD Maps-Dynamic Profiling of CD1-CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets

EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System

The EuroFlow PID Orientation Tube for Flow Cytometric Diagnostic Screening of Primary Immunodeficiencies of the Lymphoid System